{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:37:53Z","timestamp":1769503073898,"version":"3.49.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Biodefense and Emerging Infections Research Resources Repository"},{"name":"American Type Culture Collection"},{"name":"Coli Genetic Stock Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bioorg.2019.103517","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T19:19:36Z","timestamp":1576610376000},"page":"103517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Synthesis and antimicrobial evaluation of new halogenated 1,3-Thiazolidin-4-ones"],"prefix":"10.1016","volume":"95","author":[{"given":"Shaymaa G.","family":"Hammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa G.","family":"El-Gazzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader S.","family":"Abutaleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabell","family":"Ramming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Z.","family":"Elrazaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Bilitewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled A.M.","family":"Abouzid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebaa M.","family":"El-Hossary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bioorg.2019.103517_b0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3201\/eid2108.141156","article-title":"Drivers of emerging infectious disease events as a framework for digital detection","volume":"21","author":"Olson","year":"2015","journal-title":"Emerg. Infect. Dis."},{"issue":"9459","key":"10.1016\/j.bioorg.2019.103517_b0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.bioorg.2019.103517_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103517_b0020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","article-title":"The negative impact of antibiotic resistance","volume":"22","author":"Friedman","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioorg.2019.103517_b0025","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1039\/C9MD90010A","article-title":"The global antibiotic research and development partnership (GARDP): researching and developing new antibiotics to meet global public health needs","volume":"10","author":"Piddock","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2019.103517_b0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2013.11.017","article-title":"4-Thiazolidinones: the advances continue\u2026","volume":"72","author":"Tripathi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103517_b0035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bioorg.2017.10.014","article-title":"Synthetic and medicinal perspective of thiazolidinones: a review","volume":"75","author":"Manjal","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103517_b0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2018.10.008","article-title":"Novel indole-thiazolidinone conjugates: design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents","volume":"160","author":"Abo-Ashour","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103517_b0045","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1039\/C8NJ03671C","article-title":"Synthesis, structural, biological and in silico studies of new 5-arylidene-4-thiazolidinone derivatives as possible anticancer, antimicrobial and antitubercular agents","volume":"43","author":"Kumar","year":"2019","journal-title":"New J. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cbdd.12299","article-title":"Discovery of the Highly Potent Fluoroquinolone-Based Benzothiazolyl-4-thiazolidinone Hybrids as Antibacterials","volume":"84","author":"Patel","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103517_b0055","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1002\/jhet.2889","article-title":"2-(3, 4-Dichlorophenylimino)-5-((3-(p-substitutedphenyl)-1-phenyl-1H-pyrazol-4-yl) methylene) thiazolidin-4-one as an Antibacterial, Antifungal and Antimycobacterial Agent","volume":"54","author":"Brahmbhatt","year":"2017","journal-title":"J. Heterocycl. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2019.103517_b0060","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s00044-011-9864-1","article-title":"Effect of chloro and fluoro groups on the antimicrobial activity of 2, 5-disubstituted 4-thiazolidinones: a comparative study","volume":"21","author":"Chawla","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103517_b0065","first-page":"1017","article-title":"Synthesis and evaluation of thiazolidinone\u2013pyrazole conjugates as anticancer and antimicrobial agents, Future","volume":"10","author":"Bhat","year":"2018","journal-title":"Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2019.103517_b0070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejmech.2006.12.025","article-title":"Synthesis and antimicrobial evaluation of some new thiazole, thiazolidinone and thiazoline derivatives starting from 1-chloro-3,4-dihydronaphthalene-2-carboxaldehyde","volume":"42","author":"Bondock","year":"2007","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103517_b0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5012\/jkcs.2012.56.3.341","article-title":"Synthesis and Antimicrobial Evaluation of Some Novel 2-(4-Chlorophenylimino) thiazolidin-4-one Derivatives","volume":"56","author":"BBhatt","year":"2012","journal-title":"J. Korean Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103517_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/138945010790711996","article-title":"Halogen atoms in the modern medicinal chemistry: hints for the drug design","volume":"11","author":"Hernandes","year":"2010","journal-title":"Curr. Drug Targets"},{"issue":"21","key":"10.1016\/j.bioorg.2019.103517_b0085","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/14756366.2015.1016514","article-title":"Design, synthesis, antimicrobial evaluation and molecular docking studies of some new 2, 3-dihydrothiazoles and 4-thiazolidinones containing sulfisoxazole","volume":"31","author":"Nasr","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2019.103517_b0095","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1039\/c2md20079a","article-title":"The use of phosphate bioisosteres in medicinal chemistry and chemical biology","volume":"3","author":"Elliott","year":"2012","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2019.103517_b0100","series-title":"Wiley Encyclopedia of Chemical Biology","article-title":"Phosphate Mimics: Cyclic Compounds","author":"Nottbohm","year":"2008"},{"issue":"3","key":"10.1016\/j.bioorg.2019.103517_b0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","article-title":"Covalent modifiers: A chemical perspective on the reactivity of \u03b1, \u03b2-unsaturated carbonyls with thiols via hetero-Michael addition reactions","volume":"60","author":"Jackson","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103517_b0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.09.031","article-title":"5-Ene-4-thiazolidinones\u2013An efficient tool in medicinal chemistry","volume":"140","author":"Kaminskyy","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103517_b0115","first-page":"44","article-title":"1.2 Designing Covalent Inhibitors: a medicinal chemistry challenge, biomedical chemistry, sciendo","author":"Lopes","year":"2015","journal-title":"Migration"},{"key":"10.1016\/j.bioorg.2019.103517_b0120","series-title":"Progress in Medicinal Chemistry, Zoe Kruze","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmch.2018.12.002","article-title":"Covalent binders in drug discovery","author":"Vasudevan","year":"2019"},{"issue":"10","key":"10.1016\/j.bioorg.2019.103517_b0125","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1007\/s00044-013-0512-9","article-title":"Synthesis and antimicrobial screening of 5-(benzylidene)-3-phenylthiazolidin-4-one derivatives incorporating thiazole ring","volume":"22","author":"Desai","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"16","key":"10.1016\/j.bioorg.2019.103517_b0130","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1016\/j.bmc.2018.08.004","article-title":"5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation","volume":"26","author":"Fesatidou","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103517_b0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.str.2011.03.015","article-title":"Biogenesis, regulation, and targeting of the type III secretion system","volume":"19","author":"Izor\u00e9","year":"2011","journal-title":"Structure"},{"issue":"4","key":"10.1016\/j.bioorg.2019.103517_b0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2008.08.001","article-title":"An inhibitor of gram-negative bacterial virulence protein secretion","volume":"4","author":"Felise","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"22","key":"10.1016\/j.bioorg.2019.103517_b0145","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1021\/jm8004515","article-title":"Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion","volume":"51","author":"Kline","year":"2008","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103517_b0150","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bmcl.2009.01.047","article-title":"Tethered thiazolidinone dimers as inhibitors of the bacterial type III secretion system","volume":"19","author":"Kline","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.bioorg.2019.103517_b0155","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1016\/j.bmcl.2012.09.073","article-title":"Synthesis and antibiofilm activity of marine natural product-based 4-thiazolidinones derivatives","volume":"22","author":"Rane","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"49","key":"10.1016\/j.bioorg.2019.103517_b0160","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1016\/j.tetlet.2017.10.070","article-title":"Ultrasound assisted, VOSO4 catalyzed synthesis of 4-thiazolidinones: Antimicrobial evaluation of indazole-4-thiazolidinone derivatives","volume":"58","author":"Angapelly","year":"2017","journal-title":"Tetrahedron Lett."},{"issue":"05","key":"10.1016\/j.bioorg.2019.103517_b0165","doi-asserted-by":"crossref","first-page":"007","DOI":"10.7324\/JAPS.2016.60502","article-title":"Synthesis and antibacterial activity of novel 2-(arylimino) thiazolidin-4-one and 2-(benzylidenehydrazono)-3-arylthiazolidin-4-one derivatives","volume":"6","author":"El-Hossary","year":"2016","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2019.103517_b0170","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3389\/fmicb.2017.01715","article-title":"Chalcone attenuates Staphylococcus aureus virulence by targeting sortase A and alpha-hemolysin","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0175","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/IAI.70.2.631-641.2002","article-title":"Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease","volume":"70","author":"Jarraud","year":"2002","journal-title":"Infect. Immun."},{"issue":"13","key":"10.1016\/j.bioorg.2019.103517_b0180","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1021\/jm200111g","article-title":"Synthesis and antimalarial activity of 2-guanidino-4-oxoimidazoline derivatives","volume":"54","author":"Liu","year":"2011","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-9063(199802)52:2<145::AID-PS677>3.0.CO;2-J","article-title":"Antifungal activity of 1, 3-disubstituted symmetrical and unsymmetrical thioureas","volume":"52","author":"Ramadas","year":"1998","journal-title":"Pestic. Sci."},{"issue":"22","key":"10.1016\/j.bioorg.2019.103517_b0190","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1021\/jm00048a005","article-title":"Synthesis and diuretic activity of alkyl-and arylguanidine analogs of N, N'-dicyclohexyl-4-morpholinecarboxamidine in rats and dogs","volume":"37","author":"Perricone","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103517_b0195","series-title":"Thiadiazines","first-page":"16","author":"Ikeda","year":"1979"},{"key":"10.1016\/j.bioorg.2019.103517_b0200","series-title":"Advanced Organic Chemistry: Part B: Reaction and Synthesis","author":"Carey","year":"2007"},{"key":"10.1016\/j.bioorg.2019.103517_b0205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejmech.2012.06.052","article-title":"Synthesis, characterization and structure optimization of a series of thiazolidinone derivatives as Entamoeba histolytica inhibitors","volume":"55","author":"Mushtaque","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103517_b0210","series-title":"The knoevenagel reaction","author":"Tietze","year":"1992"},{"issue":"16","key":"10.1016\/j.bioorg.2019.103517_b0215","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1021\/jm400710k","article-title":"Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis","volume":"56","author":"Poyraz","year":"2013","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103517_b0220","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/ja00864a031","article-title":"On the mechanism of Schiff base formation and hydrolysis","volume":"84","author":"Cordes","year":"1962","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103517_b0225","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3390\/molecules19033068","article-title":"Synthesis of novel highly functionalized 4-thiazolidinone derivatives from 4-phenyl-3-thiosemicarbazones","volume":"19","author":"Benmohammed","year":"2014","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/088532829501000104","article-title":"A review of the effects of gamma radiation on pharmaceutical materials","volume":"10","author":"Jacobs","year":"1995","journal-title":"J. Biomater. Appl."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0235","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/104265090970322","article-title":"Synthesis and biological activity of some novel thieno [2, 3-b] quinoline, quinolino [3\u2032, 2\u2032: 4, 5] thieno [3, 2-d] pyrimidine and pyrido [2\u2032, 3\u2032: 4, 5] thieno [2, 3-b] quinoline derivatives","volume":"181","author":"El-Gaby","year":"2006","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"issue":"10","key":"10.1016\/j.bioorg.2019.103517_b0240","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.radphyschem.2010.04.014","article-title":"Study on gamma and electron beam sterilization of third generation cephalosporins cefdinir and cefixime in solid state","volume":"79","author":"Singh","year":"2010","journal-title":"Radiat. Phys. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tca.2010.11.024","article-title":"The influence of radiation sterilisation on some \u03b2-blockers in the solid state","volume":"514","author":"Marciniec","year":"2011","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.bioorg.2019.103517_b0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejbt.2016.11.009","article-title":"Radiolytic studies of cefozopran hydrochloride in the solid state","volume":"25","author":"Zalewski","year":"2017","journal-title":"Electron. J. Biotechnol."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radphyschem.2004.02.006","article-title":"Radiostability of pharmaceuticals under different irradiation conditions","volume":"72","author":"Crucq","year":"2005","journal-title":"Radiat. Phys. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0260","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103517_b0265","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1991.00400050040010","article-title":"Mechanisms of bacterial resistance to antibiotics","volume":"151","author":"Dever","year":"1991","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103517_b0270","doi-asserted-by":"crossref","first-page":"e01172","DOI":"10.1128\/mBio.01172-17","article-title":"Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria","volume":"8","author":"Krishnamoorthy","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.bioorg.2019.103517_b0275","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2147\/IDR.S156995","article-title":"Understanding antibiotic resistance via outer membrane permeability","volume":"11","author":"Ghai","year":"2018","journal-title":"Infect. Drug Resist."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103517_b0280","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","article-title":"Outer membrane permeability and antibiotic resistance","volume":"1794","author":"Delcour","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.bioorg.2019.103517_b0285","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann. Pharmacother."},{"issue":"11","key":"10.1016\/j.bioorg.2019.103517_b0290","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acsinfecdis.5b00097","article-title":"Permeability barrier of Gram-negative cell envelopes and approaches to bypass it","volume":"1","author":"Zgurskaya","year":"2015","journal-title":"ACS Infect. Dis."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103517_b0295","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/AAC.34.9.1787","article-title":"Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta mu H)","volume":"34","author":"Capobianco","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0300","first-page":"215","article-title":"AcrAB and related multidrug efflux pumps of Escherichia coli","volume":"3","author":"Nikaido","year":"2001","journal-title":"J. Mol. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/AAC.00715-09","article-title":"Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence","volume":"54","author":"Padilla","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103517_b0310","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.46.8.2640-2643.2002","article-title":"The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes","volume":"46","author":"Pradel","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0315","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/jb.178.1.306-308.1996","article-title":"AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants","volume":"178","author":"Okusu","year":"1996","journal-title":"J. Bacteriol."},{"issue":"12","key":"10.1016\/j.bioorg.2019.103517_b0320","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrate Specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM Efflux Pumps in <em>Pseudomonas aeruginosa<\/em>","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103517_b0325","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbamem.2011.08.020","article-title":"The Bam machine: A molecular cooper","volume":"1818","author":"Ricci","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.bioorg.2019.103517_b0330","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/jac\/dkl380","article-title":"Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation","volume":"59","author":"Schumacher","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"10.1016\/j.bioorg.2019.103517_b0335","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4155\/fmc.11.43","article-title":"Antivirulence agents against MRSA","volume":"3","author":"Shoham","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103517_b0340","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect. Drug Resist."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0345","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cjoc.201800470","article-title":"Chemical Intervention on Staphylococcus aureus Virulence","volume":"37","author":"Zhou","year":"2019","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.bioorg.2019.103517_b0350","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fcimb.2019.00074","article-title":"Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition","volume":"9","author":"Mart\u00ednez","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0355","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/MMBR.00052-12","article-title":"Role of pore-forming toxins in bacterial infectious diseases","volume":"77","author":"Los","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2019.103517_b0360","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1128\/IAI.00442-12","article-title":"Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection","volume":"80","author":"Rauch","year":"2012","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0365","doi-asserted-by":"crossref","first-page":"e1003871","DOI":"10.1371\/journal.ppat.1003871","article-title":"Igniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis","volume":"10","author":"Powers","year":"2014","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.bioorg.2019.103517_b0370","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/toxins5061140","article-title":"Staphylococcus aureus \u03b1-toxin: nearly a century of intrigue","volume":"5","author":"Berube","year":"2013","journal-title":"Toxins"},{"issue":"30","key":"10.1016\/j.bioorg.2019.103517_b0375","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1073\/pnas.1001815107","article-title":"Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus \u03b1-hemolysin\u2013mediated cellular injury","volume":"107","author":"Wilke","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0380","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijantimicag.2008.02.009","article-title":"Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus","volume":"32","author":"Kwon","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0385","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1590\/S0074-02762011000100008","article-title":"High vancomycin resistance among biofilms produced by Staphylococcus species isolated from central venous catheters","volume":"106","author":"Antunes","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"12","key":"10.1016\/j.bioorg.2019.103517_b0390","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/acsinfecdis.8b00172","article-title":"Naphthylthiazoles: Targeting Multidrug-Resistant and Intracellular Staphylococcus aureus with Biofilm Disruption Activity","volume":"4","author":"Hagras","year":"2018","journal-title":"ACS Infect. Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103517_b0395","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4248\/IJOS11026","article-title":"The clinical impact of bacterial biofilms","volume":"3","author":"H\u00f8iby","year":"2011","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.bioorg.2019.103517_b0400","unstructured":"Clinical Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, ninth ed.2012. Approved standard. M07-A9. Wayne, Pa."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0405","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijantimicag.2018.09.018","article-title":"Antibacterial and antivirulence activities of auranofin against Clostridium difficile","volume":"53","author":"AbdelKhalek","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2019.103517_b0410","unstructured":"Clinical Laboratory Standards Institute, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Third ed., 2008. Approved standard M27-A9. Wayne, PA."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103517_b0415","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ja.2014.142","article-title":"Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant Staphylococci","volume":"68","author":"Mohammad","year":"2015","journal-title":"J. Antibiot."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103517_b0420","doi-asserted-by":"crossref","first-page":"16407","DOI":"10.1038\/srep16407","article-title":"Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent","volume":"5","author":"Thangamani","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2019.103517_b0425","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejmech.2018.03.044","article-title":"Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity","volume":"151","author":"Kotb","year":"2018","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819318991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819318991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:54:00Z","timestamp":1758614040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819318991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":85,"alternative-id":["S0045206819318991"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103517","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and antimicrobial evaluation of new halogenated 1,3-Thiazolidin-4-ones","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103517"}}